Last 12 months
Inside the activity.
1 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2021 Filed Jan 3, 2022 21:12 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,109 | $27.61 | $30,619.49 |
DisclosureSEC source: 0001127602-22-000095 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,289 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:10 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 1,109 | $27.61 | $30,619.49 |
DisclosureSEC source: 0001127602-22-000092 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,889 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:07 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 1,109 | $27.61 | $30,619.49 |
DisclosureSEC source: 0001127602-22-000087 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,767 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 15, 2021 Filed Dec 31, 2021 00:29 UTC |
APPIO THOMASCEO, Pharma Business
|
Tax withholdingCommon Shares, No Par Value | 3,461 | $24.49 | $84,759.89 |
DisclosureSEC source: 0001127602-21-032076 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · CEO, Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,225 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| November 30, 2021 Filed Dec 3, 2021 00:15 UTC |
Miller Steven DDirector
|
PurchaseCommon Shares, No Par Value | 10,000 | $24.17 | $241,699.00 |
DisclosureSEC source: 0001127602-21-030159 · form4.xml · nonDerivative · entry 2 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 10,000 Read SEC document |
| November 30, 2021 Filed Dec 3, 2021 00:15 UTC |
Miller Steven DDirector
|
PurchaseCommon Shares, No Par Value | 50,000 | $24.24 | $1,211,825.00 |
DisclosureSEC source: 0001127602-21-030159 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,780 Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 21:09 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantCommon Shares, No Par Value | 1,246 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-028498 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,418 F1 · price: Represents the award of restricted share units ("RSUs") which will vest one-half on each of the first two anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares"). Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:36 UTC |
Spurr RobertU.S. President-Pharma Business
|
Tax withholdingCommon Shares, No Par Value | 283 | $28.60 | $8,093.80 |
DisclosureSEC source: 0001127602-21-026682 · form4.xml · nonDerivative · entry 1 Spurr Robert · CIK 0001543795 · U.S. President-Pharma Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,801 Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:48 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 246 | $27.85 | $6,851.10 |
DisclosureSEC source: 0001127602-21-026458 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,805 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:47 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,368 | $27.85 | $38,098.80 |
DisclosureSEC source: 0001127602-21-026457 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,205 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:46 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,099 | $27.85 | $30,607.15 |
DisclosureSEC source: 0001127602-21-026454 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,180 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:44 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 1,099 | $27.85 | $30,607.15 |
DisclosureSEC source: 0001127602-21-026453 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,780 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:41 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,234 | $27.85 | $34,366.90 |
DisclosureSEC source: 0001127602-21-026451 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,343 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:42 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 1,099 | $27.85 | $30,607.15 |
DisclosureSEC source: 0001127602-21-026452 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,658 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:15 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Tax withholdingCommon Shares, No Par Value | 5,010 | $28.66 | $143,586.60 |
DisclosureSEC source: 0001127602-21-025347 · form4.xml · nonDerivative · entry 2 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,031,419 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 21:15 UTC |
PAPA JOSEPH CDirector · CHAIRMAN & CEO
|
Tax withholdingCommon Shares, No Par Value | 3,549 | $29.19 | $103,595.31 |
DisclosureSEC source: 0001127602-21-025347 · form4.xml · nonDerivative · entry 1 PAPA JOSEPH C · CIK 0001242215 · Director · CHAIRMAN & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,429 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:10 UTC |
Spurr RobertPresident, Salix
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 31,400 | $0.00 Strike: $28.85 | $0.00 |
DisclosureSEC source: 0001127602-21-024867 · form4.xml · derivative · entry 2 Spurr Robert · CIK 0001543795 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,400 Underlying: Common Shares, No Par Value · 31,400 shares Expires 2031-09-01 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:10 UTC |
Spurr RobertPresident, Salix
|
GrantCommon Shares, No Par Value | 9,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024867 · form4.xml · nonDerivative · entry 1 Spurr Robert · CIK 0001543795 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,084 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:09 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
GrantRestricted Share Units · Derivative | 90,260 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024865 · form4.xml · derivative · entry 2 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,260 Underlying: Common Shares, No Par Value · 90,260 shares Expires not disclosed F2 · derivative.exercise_price: Represents a grant of performance-based RSUs ("PSUs"), each of which represents a contingent right to receive one Common Share. The number of Common Shares to be distributed upon the vesting of the PSUs will be determined by the Issuer's Total Shareholder Return ("TSR"), as measured for the 20 trading days preceding the TSR measurement date, and will be between 0% to 200% of the PSU target reported in Column 5. F2 · derivative.exercise_date: Represents a grant of performance-based RSUs ("PSUs"), each of which represents a contingent right to receive one Common Share. The number of Common Shares to be distributed upon the vesting of the PSUs will be determined by the Issuer's Total Shareholder Return ("TSR"), as measured for the 20 trading days preceding the TSR measurement date, and will be between 0% to 200% of the PSU target reported in Column 5. F2 · derivative.expiration_date: Represents a grant of performance-based RSUs ("PSUs"), each of which represents a contingent right to receive one Common Share. The number of Common Shares to be distributed upon the vesting of the PSUs will be determined by the Issuer's Total Shareholder Return ("TSR"), as measured for the 20 trading days preceding the TSR measurement date, and will be between 0% to 200% of the PSU target reported in Column 5. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:09 UTC |
APPIO THOMASPres&Co-Head Bausch&Lomb/Int'l
|
GrantCommon Shares, No Par Value | 90,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024865 · form4.xml · nonDerivative · entry 1 APPIO THOMAS · CIK 0001683323 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,686 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares"). Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:09 UTC |
Spurr RobertPresident, Salix
|
Tax withholdingCommon Shares, No Par Value | 1,278 | $28.95 | $36,998.10 |
DisclosureSEC source: 0001127602-21-024581 · form4.xml · nonDerivative · entry 1 Spurr Robert · CIK 0001543795 · President, Salix 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,058 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:07 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Tax withholdingCommon Shares, No Par Value | 5,017 | $28.95 | $145,242.15 |
DisclosureSEC source: 0001127602-21-024579 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,741 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:13 UTC |
VON ESCHENBACH ANDREW C.Director
|
PurchaseCommon Shares, No Par Value | 1,400 | $25.94 | $36,316.00 |
DisclosureSEC source: 0001127602-21-023339 · form4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,647 Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 20:24 UTC |
DE SCHUTTER RICHARD UDirector
|
PurchaseCommon Shares, No Par Value | 10,000 | $25.01 | $250,123.00 |
DisclosureSEC source: 0001127602-21-023267 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,109 F1 · price: The price in Column 4 reflects the average weighted purchase price for the transactions aggregated on this Form 4. The purchase price per share reported on this Form 4 range from $25.00 to $25.03. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:18 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 234 | $29.32 | $6,860.88 |
DisclosureSEC source: 0001127602-21-021238 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,559 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:15 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,300 | $29.32 | $38,116.00 |
DisclosureSEC source: 0001127602-21-021231 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,837 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:13 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,044 | $29.32 | $30,610.08 |
DisclosureSEC source: 0001127602-21-021229 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,081 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:11 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 1,044 | $29.32 | $30,610.08 |
DisclosureSEC source: 0001127602-21-021220 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:09 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 1,044 | $29.32 | $30,610.08 |
DisclosureSEC source: 0001127602-21-021214 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,559 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:06 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,172 | $29.32 | $34,363.04 |
DisclosureSEC source: 0001127602-21-021208 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,109 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 20:11 UTC |
Eldessouky SamEVP & Chief Financial Officer
|
SaleCommon Shares, No Par Value | 17,000 | $31.68 | $538,585.50 |
DisclosureSEC source: 0001127602-21-019904 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,857 F1 · price: The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4. The sales price per share reported on this Form 4 range from $31.67 to $31.711. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:51 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Exercise / conversionNon-Qualified Stock Options (right to purchase) · Derivative | 60,853 | $0.00 Strike: $15.32 | $0.00 |
DisclosureSEC source: 0001127602-21-019273 · form4.xml · derivative · entry 5 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 60,853 shares Expires 2028-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:51 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Exercise / conversionNon-Qualified Stock Options (right to purchase) · Derivative | 60,345 | $0.00 Strike: $14.38 | $0.00 |
DisclosureSEC source: 0001127602-21-019273 · form4.xml · derivative · entry 4 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 60,345 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:51 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
SaleCommon Shares, No Par Value | 121,198 | $31.83 | $3,857,732.34 |
DisclosureSEC source: 0001127602-21-019273 · form4.xml · nonDerivative · entry 3 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,758 F1 · price: The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4. The sales price per share reported on this Form 4 range from $31.61 to $32.11. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:51 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Exercise / conversionCommon Shares, No Par Value | 60,853 | $15.32 | $932,267.96 |
DisclosureSEC source: 0001127602-21-019273 · form4.xml · nonDerivative · entry 2 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:51 UTC |
ACKERMANN CHRISTINAEVP AND GENERAL COUNSEL
|
Exercise / conversionCommon Shares, No Par Value | 60,345 | $14.38 | $867,761.10 |
DisclosureSEC source: 0001127602-21-019273 · form4.xml · nonDerivative · entry 1 ACKERMANN CHRISTINA · CIK 0001681871 · EVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:26 UTC |
Eldessouky SamEVP & Chief Financial Officer
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 122,427 | $32.03 Strike: $32.03 | $3,921,336.81 |
DisclosureSEC source: 0001127602-21-019037 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,427 Underlying: Common Shares, No Par Value · 122,427 shares Expires 2031-06-01 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:26 UTC |
Eldessouky SamEVP & Chief Financial Officer
|
GrantCommon Shares, No Par Value | 33,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-019037 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,857 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:34 UTC |
WECHSLER AMY BDirector
|
SaleCommon Shares, No Par Value | 11,037 | $31.79 | $350,811.05 |
DisclosureSEC source: 0001127602-21-018330 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,325 Read SEC document |
| April 30, 2021 Filed May 3, 2021 23:27 UTC |
Hale David RobertDirector · See Remarks
ValueAct Holdings, L.P.Director · See Remarks
ValueAct Capital Master Fund, L.P.Director · See Remarks
VA Partners I, LLCDirector · See Remarks
ValueAct Capital Management, L.P.Director · See Remarks
ValueAct Capital Management, LLCDirector · See Remarks
ValueAct Holdings II, L.P.Director · See Remarks
ValueAct Holdings GP, LLCDirector · See Remarks
|
GrantCommon Shares, no par value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001418812-21-000021 · primary_doc.xml · nonDerivative · entry 1 Hale David Robert · CIK 0001635643 · Director · See Remarks ValueAct Holdings, L.P. · CIK 0001418814 · Director · See Remarks ValueAct Capital Master Fund, L.P. · CIK 0001464912 · Director · See Remarks VA Partners I, LLC · CIK 0001418812 · Director · See Remarks ValueAct Capital Management, L.P. · CIK 0001351069 · Director · See Remarks ValueAct Capital Management, LLC · CIK 0001351073 · Director · See Remarks ValueAct Holdings II, L.P. · CIK 0001763309 · Director · See Remarks ValueAct Holdings GP, LLC · CIK 0001418813 · Director · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,682 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. F2 · ownership.direct: All board compensation accrues to the benefit of the investors in ValueAct Capital Master Fund, L.P., and not to any individual. Under an agreement with ValueAct Capital, D. Robert Hale is deemed to hold the restricted share units for the benefit of the limited partners of ValueAct Capital Master Fund, L.P. and indirectly for the entities listed in (i) to (vi) footnote 4 herein. F3 · ownership.direct: Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:16 UTC |
WECHSLER AMY BDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014921 · form4.xml · nonDerivative · entry 1 WECHSLER AMY B · CIK 0001677300 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,362 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:15 UTC |
VON ESCHENBACH ANDREW C.Director
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014919 · form4.xml · nonDerivative · entry 1 VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,247 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:13 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014914 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,537 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:14 UTC |
Ross Thomas W. Sr.Director
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014916 · form4.xml · nonDerivative · entry 1 Ross Thomas W. Sr. · CIK 0001669396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,924 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:11 UTC |
POWER ROBERT NDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014912 · form4.xml · nonDerivative · entry 1 POWER ROBERT N · CIK 0001187303 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,424 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:09 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014911 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,037 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:08 UTC |
Miller Steven DDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014910 · form4.xml · nonDerivative · entry 1 Miller Steven D · CIK 0001844277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,637 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:04 UTC |
KAVANAGH SARAH BDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014908 · form4.xml · nonDerivative · entry 1 KAVANAGH SARAH B · CIK 0001681171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,060 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:07 UTC |
KARABELAS ARGERIS NDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014909 · form4.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,328 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:03 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014907 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,515 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.